BionicM Earns FDA Registration and Class II Exempt Device Listing for Bio Legtm; Its New Motor-Robotic Prosthetic Knee
TOKYO, Aug. 30, 2023 /PRNewswire/ -- BionicM, an innovative Japanese medical device startup, is pleased to announce that it has received U.S. Food and Drug Administration (FDA) 510(k) exemption registration for Bio Legtm; its robotic prosthetic knee. This registration marks a significant milestone in the company's commitment to deliver its robotic prosthetic knee to the USA market in 2024 with Japanese-proven technologies.
"Having your limbs amputated severely limits your life," says Xiaojun Sun, CEO of BionicM, and an above-knee amputee. "While prosthetic limbs have been developed, there are many new ways to improve the lives of amputees with advanced technology. This milestone of achieving our FDA registration underscores our dedication to developing state-of-the-art prosthetic solutions that have the potential to revolutionize mobility of people who have limb loss."
"Bio Legtm is a groundbreaking prosthetic knee joint which can help improve the daily activities of limb loss in transfemoral patients. We have done several trial fittings in my New York facility with very good results," says Gary Marano, CPO, LPO and CEO of OTF Prosthetics and Orthotics in New York. "Bio Legtm allows a more natural gait to walk long distances more efficiently along with stability using ramps and inclines. Another functional benefit is to provide an easier sit to stand feature giving the user a quicker and smoother transition when standing up from a chair."
Bio Legtm features include:
Bio Legtm assists a wide range of movements with power, such as ascending and descending stairs and sitting on and standing up from a chair.
Bio Legtm bends the knees with power and actualizes graceful walking without stumbling, even when walking slowly or in small steps, by using power to bend the knees and lift the toes from the ground during the swing phase.
Bio Legtm prevents knee buckling by assisting the extension of the knee during the stance phase. Users can safely put their weight on the prosthetic leg.
Bio Legtm provides an easier sit to stand feature giving the user a quicker and smoother transition when standing up from a chair; this feature will also assist those who have had a stroke, weakness, or arthritis in the hip or knee joint on the contralateral side.
To get more information about Bio Legtm, please visit company's homepage: https://bionicm.com/. The company will also be showcasing Bio Legtm at the upcoming AOPA Conference in Indianapolis in September. Contact [email protected] or visit booth #224.
About BionicM BionicM has been researching on innovative technologies since 2015 at the University of Tokyo, utilizing the world's most advanced robotics research. BionicM won several research grants and awards for start-ups. The robotic prosthetic knee Bio Legtm also won the Grand Prix "Luminary" in the design concept category of the 2020 "Red Dot Award," one of the world's highest design awards.
Media Contact: Name: Naoko Kita Marketing & Sales Department, BionicM Inc. [email protected] +81-3-3868-2679
Immunovia (STO: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today announces the appointment of Dr. Lisa Ford as Clinical Laboratory Director.
As Clinical Laboratory Director, Dr. Ford will...
Immunovia , the diagnostics company seeking to increase pancreatic cancer survival through early detection, today announces that the company will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024.
The move to...
Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events:
2024 RBC Capital Markets Global Healthcare Conference ? May 14-15, 2024
Type: Fireside Chat Presentation
Date/Time: May 14,...
Prota Therapeutics' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor Tang's exceptional work as a lead researcher for the Murdoch Children's Research Institute (MCRI) and her...
International medical imaging IT and Cybersecurity company Sectra's (STO: SECT B) digital pathology solution together with Leica Biosystems, Imaging, Inc.'s Aperio GT 450 DX have received a 510(k) clearance by the US Food & Drug Administration (FDA)....
Author C.A. Blake was 24 years old when her brother, Steve, committed suicide. She struggled with the feeling she wouldn't survive the pain of it. Growing up in a time where little to no coping skills were taught or offered, she traveled the path of...